Hennion & Walsh Asset Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.54M Buy
115,185
+3,780
+3% +$75.9K 0.07% 317
2026
Q2
$2.29M Buy
111,405
+27,395
+33% +$464K 0.07% 349
2026
Q1
$1.34M Buy
84,010
+17,820
+27% +$387K 0.04% 442
2025
Q4
$1.74M Buy
+66,190
New +$1.72M 0.06% 385

Other funds holding FLGT

Hennion & Walsh Asset Management's FLGT Position: Q3 2026 in Review

Hennion & Walsh Asset Management increased its Fulgent Genetics (FLGT) stake by 3.4% in Q3 2026, buying an estimated $75.9K and bringing the position to 115,185 shares worth $2.54M. The position accounts for 0.07% of the portfolio, ranked #317.

Hennion & Walsh Asset Management first reported a position in FLGT in Q4 2025 and has held it in 4 quarters since. 10 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.

  • Hennion & Walsh Asset Management held 115,185 shares of Fulgent Genetics worth $2.54M as of Q3 2026.
  • Hennion & Walsh Asset Management bought 3,780 Fulgent Genetics shares in Q3 2026, an estimated $75.9K.
  • Fulgent Genetics made up 0.07% of Hennion & Walsh Asset Management's portfolio in Q3 2026, its #317 holding.
  • Hennion & Walsh Asset Management first reported a position in Fulgent Genetics in Q4 2025 and has held it in 4 quarters since.
  • 10 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.